TY  - CONF

T1  - Tolerability and efficacy of palbociclib in combination with an aromatase inhibitor (AI) in older women (≥75 years) with ER +ve, HER2-ve metastatic breast cancer. A large 'real world' UK multi-centre study

JO  - CANCER RESEARCH

PY  - 2021/01/01

AU  - El Badri S

AU  - Hills D

AU  - Synowiec A

AU  - Harper-Wynne C

AU  - Moe M

AU  - Wilson C

ED  - 

VL  - 81

IS  - 4

Y2  - 2025/10/10

ER  -